MAIN-CAV: Phase III randomized trial of maintenance cabozantinib and avelumab versus avelumab after first-line platinum-based chemotherapy in patients (pts) with metastatic urothelial cancer (mUC) (Alliance A032001).
- Citation:
- J Clin Oncol vol 41 (suppl 16) TPS4609
- Meeting Instance:
- ASCO 2023
- Year:
- 2023
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- No-Endpoint
- Analysis:
- Trial-Description-Only
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epreprint
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- U10CA180821, U10CA180882; U24CA196171, U10CA180863 (CCTG);
- Corr. Author:
- Authors:
- Shilpa Gupta Karla V. Ballman Matthew D. Galsky Michael J. Morris Srikala Sridhar Ronald Chen Timothy M. Chan Yujia Wen Aihua Edward Yen Petros Grivas Himanshu Nagar Alan Tan Shiva Baghaie Jonathan E. Rosenberg
- Networks:
- Study
- Alliance-A032001
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: